Ziprasidone in the Psychosis Prodrome

Conditions

Psychosis Prodrome

Trial Phase

Phase 2

Trial Purpose and Description

Trial Purpose

This study aims to determine whether ziprasidone is superior to placebo over 24 weeks for patients with the psychosis prodrome.



Participation Guidelines

Age:
16 Years - 40 Years
Gender:
Both

Eligibility Criteria

Inclusion Criteria:

  • SIPS criteria for psychosis prodrome
  • clinically referred

Exclusion Criteria:

  • prolonged QTc
  • history of syncope
Sponsor:
Yale University
Dates:
March 2008
Last Updated:
January 13, 2010
Study HIC#:
0801003386

Clinicaltrials.gov ID: NCT00635700